Effect of the baseline vitamin D level on growth outcome in pediatric crohn disease

Eun Joo Lee, Jin Soo Moon, Jaesung Ko, Hyeran Yang, Ju Young Jang, Joo Whee Kim, Kyung Jae Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients. Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.

Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalPediatric Gastroenterology, Hepatology and Nutrition
Volume20
Issue number1
DOIs
StatePublished - 1 Mar 2017

Fingerprint

Vitamin D
Growth
Crohn Disease
Vitamin D Deficiency
Serum
Pediatric Crohn's disease
Body Mass Index
Retrospective Studies
Weights and Measures

Keywords

  • Growth
  • Pediatric Crohn's disease
  • Vitamin D

Cite this

@article{f830949a722b4b5b852fe3ae890b6aef,
title = "Effect of the baseline vitamin D level on growth outcome in pediatric crohn disease",
abstract = "Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients. Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.",
keywords = "Growth, Pediatric Crohn's disease, Vitamin D",
author = "Lee, {Eun Joo} and Moon, {Jin Soo} and Jaesung Ko and Hyeran Yang and Jang, {Ju Young} and Kim, {Joo Whee} and Lee, {Kyung Jae}",
year = "2017",
month = "3",
day = "1",
doi = "10.5223/pghn.2017.20.1.41",
language = "English",
volume = "20",
pages = "41--46",
journal = "Pediatric Gastroenterology, Hepatology and Nutrition",
issn = "2234-8646",
publisher = "Korean Society of Pediartic Gastroenterology, Hepatology and Nutrition",
number = "1",

}

Effect of the baseline vitamin D level on growth outcome in pediatric crohn disease. / Lee, Eun Joo; Moon, Jin Soo; Ko, Jaesung; Yang, Hyeran; Jang, Ju Young; Kim, Joo Whee; Lee, Kyung Jae.

In: Pediatric Gastroenterology, Hepatology and Nutrition, Vol. 20, No. 1, 01.03.2017, p. 41-46.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of the baseline vitamin D level on growth outcome in pediatric crohn disease

AU - Lee, Eun Joo

AU - Moon, Jin Soo

AU - Ko, Jaesung

AU - Yang, Hyeran

AU - Jang, Ju Young

AU - Kim, Joo Whee

AU - Lee, Kyung Jae

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients. Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.

AB - Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients. Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.

KW - Growth

KW - Pediatric Crohn's disease

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85017628381&partnerID=8YFLogxK

U2 - 10.5223/pghn.2017.20.1.41

DO - 10.5223/pghn.2017.20.1.41

M3 - Article

AN - SCOPUS:85017628381

VL - 20

SP - 41

EP - 46

JO - Pediatric Gastroenterology, Hepatology and Nutrition

JF - Pediatric Gastroenterology, Hepatology and Nutrition

SN - 2234-8646

IS - 1

ER -